Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target siteEmir Hadzijusufovic, Peter Valent, Christoph Kaun et al.|Leukemia|2017Cited by 155
Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CMLEmir Hadzijusufovic, Peter Valent, Karin Albrecht-Schgoer et al.|Blood|2014Cited by 6
Nilotinib exerts proatherogenic and growth-inhibitory effects on endothelial cells: a potential mechanism underlying drug-related vasculopathy in Ph plus CMLEmir Hadzijusufovic, Peter Valent, Karin Albrecht-Schgoer et al.|Unknown|2014Cited by 0
Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib on Endothelial Cells: A Potential Mechanism to Explain Vasculopathies in Cml Patients Treated With NilotinibEmir Hadzijusufovic, Peter Valent, Giulio Superti‐Furga et al.|Unknown|2014Cited by 0